News

Vertex raises its 2026 revenue outlook as CF growth, newer products and a near-term renal launch strengthen its diversification push.

SNAP puts free cash flow per share first as ad gains, subscription growth and disciplined Specs spending aim to drive durable cash generation.

ON raises its 2026 AI data center outlook to more than double last year as tighter supply and higher factory utilization support Q3 revenue and margin growth.

Ichor expects a steeper second-half revenue ramp, quarterly margin gains and stronger 2027 growth as supply issues ease and internal content rises.

Grab raised its 2026 outlook as on-demand growth, record users and improving fintech results strengthened its profitability push.

AEIS raises its 2026 growth outlook as semiconductor, data center and Industrial & Medical demand strengthens, extending its growth runway into 2027.

Rockwell Automation, Inc. (NYSE:ROK) reported third-quarter fiscal 2026 results that topped Wall Street expectations, but the company’s shares fell more than 4% in pre-market trading as investors focused on its updated earnings outlook.

(Bloomberg) -- The US Treasury will need to increase the sizes of at least some of its fixed-rate borrowing programs next year but is unlikely to signal the shift just yet, according to bond dealers.Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevTaco Bell Met With Michigan on Parasite Weeks Before RecallChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersApple’s New CEO Taps Retired Hardware Executive for Management TeamMamdani Dismisses Business Lead

Shares of general merchandise retailer Target (NYSE:TGT) jumped 3.1% in the afternoon session after continued momentum fueled by positive analyst sentiment and a broader market shift toward consumer staples. The stock's rise was supported by several favorable analyst actions. Gordon Haskett raised its price target to $170 with a "Buy" rating, while Wolfe Research upgraded the stock to "Outperform." Additionally, Jefferies increased its price target to $161, and Wells Fargo maintained an "Overwei

WULF readies for its Aug. 5 Q2 report with revenues and EPS expected to decline, though growing HPC lease revenues could have helped offset pressure from weaker Bitcoin mining.

Tesla's stock has cratered 30% this year while rivals like BYD eat into its European market share, but an unexpected geopolitical crisis may be handing the company a lifeline that no amount of AI hype ever could.

Wayfair (NYSE:W) shares fell around 3% in pre-market trading on Tuesday, even after the online home furnishings retailer reported second-quarter 2026 earnings and revenue that both exceeded Wall Street expectations. The company delivered solid sales growth, higher customer spending and continued gains in order volumes, but investors remained cautious following the results.

BYD posted its highest monthly sales of the year, and Leapmotor topped 100,000 units for the second straight month, beating Tesla China

ATI heads into Q2 earnings with rising aerospace demand, strategic investments and a 6.98% revenue growth estimate supporting expectations for a beat.

Qualcomm faces falling fiscal 2026 and 2027 earnings estimates as handset weakness, margin pressure and competition offset automotive and IoT gains.

A capital program set to keep growing for years has already turned free cash flow negative, and it is funding the product Tesla itself calls the hardest it has ever had to scale.

IBM's sovereign AI partnership with Sarvam targets India's public sector, while hybrid cloud demand and rising estimates support growth prospects.

Nvidia still builds the chips powering the AI revolution, but a quiet South Korean memory maker has quietly become the stock Wall Street is betting on most aggressively, and the reason why reshapes everything investors think they know about where AI profits actually flow.

Pfizer (NYSE:PFE) increased the lower end of its full-year revenue guidance after reporting second-quarter 2026 results that exceeded Wall Street expectations, supported by robust sales of its blood thinner Eliquis. The pharmaceutical company also reaffirmed its earnings outlook for the year, while its shares moved higher in U.

Shipbuilding revenue surged 15.7% as the company raised full-year guidance.

The company long defined by its professional-grade creative tools is now pursuing a radically different customer. It is retooling its entire user acquisition model to serve billions of consumers through a freemium funnel. This strategic pivot is already showing results, nearly doubling its Creative Freemium monthly active users in the last year alone. The goal is no longer just power and precision for experts but mass adoption.

ROKU heads into Q2 earnings with Platform growth expected to offset device weakness as ad trends and the pending Fox acquisition remain in focus.

Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. The Fund gained 11.99% during the quarter, compared with the 10.48% gain for the Russell 3000 Health Care Index and the 15.44% gain for the Russell 3000 Index. Since inception, […]

In the world of chip equipment, paying more for slower growth seems like a mistake, but the market is making exactly that bet on one industry leader over its faster rival.

FOXA heads into fiscal Q4 earnings with World Cup-driven sports momentum, ad demand and streaming growth in focus as investors watch quarterly results.

Here is how Applied Industrial Technologies (AIT) and Idex (IEX) have performed compared to their sector so far this year.

Here is how Atmus Filtration Technologies (ATMU) and Ford Motor Company (F) have performed compared to their sector so far this year.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here is how Perspective Therapeutics (CATX) and Bristol Myers Squibb (BMY) have performed compared to their sector so far this year.

Here is how Coca-Cola (KO) and Luckin Coffee Inc. Sponsored ADR (LKNCY) have performed compared to their sector so far this year.